Skip to content
Home/Companies/Biotech/MiroBio
MI

MiroBio

Biotech·UK·Exited 2022·Held 3yr

MiroBio is a biotech company, headquartered in UK.

Entry
2019
Hold
3yr
Exit
2022
Est. EV
–

Who owns MiroBio?

MiroBio was owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage) from 2019 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-11

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Dark Blue Therapeutics
Exited 2026
BiotechUK· 2020
to
Oxford Ionics
Exited 2025
Deep TechUK· 2019
to
PepGen
Active
BiotechUnited States· 2018
Latent Logic
Exited 2019
AI/MLUK· 2017
to
Oxford Semantic Technologies
Exited 2024
AI/MLUK· 2017
to
Brill Power
Exited 2025
EnergyUK· 2016
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings